PTC:NASDAQPTC Inc. Analysis
Data as of 2026-09-07 - not real-time
$141.02
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $141.02, PTC Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 19.0%. Relative strength is 43.0 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $140.00 and resistance around $159.46.
On valuation the read is undervalued — earnings multiple of 13.7 versus a 33.2 sector average, below the peer group. Analyst price targets sit 22.9% above the current price. Revenue is contracting at 6.8% on a 41.4% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 43.6%, a beta of 0.48 and a maximum drawdown of 47.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
On valuation the read is undervalued — earnings multiple of 13.7 versus a 33.2 sector average, below the peer group. Analyst price targets sit 22.9% above the current price. Revenue is contracting at 6.8% on a 41.4% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 43.6%, a beta of 0.48 and a maximum drawdown of 47.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Top Market Events
PTC Inc. PTC now presents a more balanced investment debate after a sharp pullback reset expectations and valuation....PTC's valuation reset and buybacks improve its risk-reward profile, but weak revenue, margin pressure and a demanding...WS Amati Global Innovation Fund, managed by a UK-based equity management firm from AMAti Global Investors, released its...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 148.72
- MACD momentum is negative
- 30-day price change of +19.0%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 13.7 versus sector average of 33.2
- Trading below the 200-day average of 148.72
- Analyst targets imply +22.9% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 13.7 versus sector average of 33.2
- Analyst targets imply +22.9% versus the current price
- Profit margin of 41.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-6.80%
Profit Margin41.43%
P/E Ratio13.7
ROE35.05%
ROA11.54%
Debt/Equity46.34
P/B Ratio4.5
Op. Cash Flow$955.3M
Free Cash Flow$1.0B
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI43.0
Support$140.00
Resistance$159.46
MA 20$151.41
MA 50$136.51
MA 200$148.72
MACDBearish
VolumeIncreasing
Fear & Greed Index94.11
Valuation
Fair Value$108.76
Target Price$173.35
Upside/Downside22.93%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.48
Volatility43.63%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.